Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Bahrain.
Press releases published on August 18, 2025

The Association of American Physicians and Surgeons Filed an Amicus Brief in the Ninth Circuit in Support of Restoring California’s Religious Exemption to Vaccination
TUCSON, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) filed its amicus brief on Friday in the U.S. Court of Appeals for the Ninth Circuit to restore in California the religious exemption to vaccination, …

HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
MIRAMAR, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal …

BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit
DALLAS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- BioNTX is pleased to announce the finalists for the Annual Southwest Tech Transfer Showcase, set for Wednesday, September 17th, at the 2025 iC³® Life Science …

WePrevent Launches Florida’s First Comprehensive Prevention Health Platform Amid $100B Chronic Disease Crisis
Miami, Florida , Aug. 18, 2025 (GLOBE NEWSWIRE) -- WePrevent, a Florida-based health innovation company, today announced the launch of WePrevent.org, the state’s first comprehensive online platform connecting residents with full-spectrum preventive care …

PD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsight
New York, USA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- PD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsight PD-1 inhibitors are projected to dominate future drug sales. Immuno- …

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
CHICAGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today its financial results for the second quarter and six-month period …

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and …

ACMA Announces Newly Elected National Board Members
Little Rock, AR, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The American Case Management Association (ACMA) is pleased to announce the results of the 2025 National Board of Directors elections. The following distinguished professionals have been elected to serve on …

Whitsons and The Abbey Group Bring Local Flavor to New England Schools
Pittsfield, VT, Aug. 18, 2025 (GLOBE NEWSWIRE) -- From Vermont’s rolling dairy farms to Massachusetts’ coastal produce markets, a new partnership is reshaping how students across New England experience school meals. Whitsons Culinary Group® and The Abbey …

Attelia Dental Clinic Wins Prestigious Quality Choice Prize 2025 in Stockholm
Photo: Founder and Chief Dentist Dr. Mehmet İşlek of Attelia Dental Clinic receiving the Quality Choice Prize 2025 award. ANTALYA, Turkey, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Attelia Oral …

Affidea partners with Skin Analytics to improve access to skin cancer assessment across Europe using AI technology
THE HAGUE, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Affidea, a leading pan-European provider of community-based polyclinics, advanced diagnostics, and multi-specialist care, including oncology, has entered a strategic partnership with Skin …

Global Ophthalmology Drugs Market to Reach USD 26.28 Billion by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- North America leads market expansion as companies advance next-generation ophthalmic therapies to address rising prevalence of vision-threatening diseases The global ophthalmology drugs market, valued at …

Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market
VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (“Hapbee” or the “Company”) (TSXV: HAPB | OTCQB: HAPBF | FWB: HA1) today announced that Smile Group, a prominent Asia‑based venture builder and growth partner, has made …

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE). The first WRAP North America patient was enrolled at Bluff City …

European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase …

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
Live video webcast on Thursday, August 21st at 1:00 PM ET Register here THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision …

European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an …

Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca (IL), United States, August 18th, 2025 – Biocartis Group of Companies (“Biocartis”), an innovative molecular …

Elucent Medical Launches SmartSupport™ – A Smarter Standard in Surgical Support
MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce the launch of SmartSupport™, a comprehensive, on-demand virtual support platform designed to enhance the procedural experience for clinicians using the EnVisio® In-Body …